Table 4.
Inflammatory cell infiltration score | |||
---|---|---|---|
Treatment regimen | Total inflammatory score of anterior section | Anterior section | Posterior section |
Group 1 (n = 8): Control - No treatment | 4.4 ± 2.6 | 0.7 ± 1.0 | 2.9 ± 1.2 |
Group 2 (n = 3): 15% DSP, 15 min, 4 doses | 0.2 ± 0.4a | 0.0 ± 0.2a | 0.1 ± 0.3a |
Group 3 (n = 2): 15% DSP, 10 min, 1 dose | 1.0 ± 1.1b | 0.2 ± 0.4b | 1.8 ± 1.5b |
Group 4 (n = 3): 8% DSP, 10 min, 1 dose | 1.8 ± 0.7b | 0.3 ± 0.7b | 1.2 ± 0.9a |
Group 5 (n = 3): 8% DSP, 5 min, 4 doses | 1.4 ± 1.7b | 0.2 ± 0.8a | 1.9 ± 1.6b |
Group 6 (n = 3): 4% DSP, 10 min, 2 doses | 1.9 ± 1.1c | 0.3 ± 0.7b | 2.9 ± 1.0 (P = 0.7) |
Statistical differences in the average scores observed between the control group and each DSP-Visulex treatment group were assessed by the Wilcoxon rank-sum test with aP < 0.001, bP < 0.01, and cP < 0.05.